Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electrical Impedance Correlated to Flow Rate in Elastomeric Valves: An Analog Material Memory.

ACS applied materials & interfaces·2025
Same author

Predicting Clinical Outcomes of SARS-CoV-2 Drug Efficacy with a High-Throughput Human Airway Microphysiological System.

Advanced biology·2024
Same author

First 24-Hour-Long Intensive Care Unit Testing of a Clinical-Scale Microfluidic Oxygenator in Swine: A Safety and Feasibility Study.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2024
Same author

A High-Throughput, High-Containment Human Primary Epithelial Airway Organ-on-Chip Platform for SARS-CoV-2 Therapeutic Screening.

Cells·2023
Same author

Bionanotechnology and bioMEMS (BNM): state-of-the-art applications, opportunities, and challenges.

Lab on a chip·2023
Same author

Report of the Assay Guidance Workshop on 3-Dimensional Tissue Models for Antiviral Drug Development.

The Journal of infectious diseases·2023
Same journal

The Heart of the Metaverse: How Immersive Technologies Are Revolutionizing Cardiac Care.

IEEE pulse·2026
Same journal

Benefits for Early Diagnosis, Treatment, and Research.

IEEE pulse·2026
Same journal

At the Crossroads of Innovation.

IEEE pulse·2026
Same journal

Robotics in the Cath Lab: Precision, Safety, and the Rise of Remote Cardiac Interventions.

IEEE pulse·2026
Same journal

Industry Corner Live With BioBeat CEO Arik Ben Ishay.

IEEE pulse·2026
Same journal

Engineering the Next Generation of Artificial Hearts.

IEEE pulse·2026
See all related articles

Related Experiment Video

Updated: Mar 24, 2026

Scalable Fabrication of Stretchable, Dual Channel, Microfluidic Organ Chips
14:44

Scalable Fabrication of Stretchable, Dual Channel, Microfluidic Organ Chips

Published on: October 20, 2018

27.7K

Organs-on-Chips: How Microsystems Technology Can Transform the Drug Development Process.

Jeffrey T Borenstein

    IEEE Pulse
    |March 16, 2016
    PubMed
    Summary
    This summary is machine-generated.

    Drug development faces significant challenges due to rising costs, long timelines, and poor preclinical study accuracy. Emerging demands like precision medicine and new diseases further strain the process.

    More Related Videos

    Generation of a Human iPSC-Based Blood-Brain Barrier Chip
    10:20

    Generation of a Human iPSC-Based Blood-Brain Barrier Chip

    Published on: March 2, 2020

    13.8K
    The Multi-organ Chip - A Microfluidic Platform for Long-term Multi-tissue Coculture
    10:05

    The Multi-organ Chip - A Microfluidic Platform for Long-term Multi-tissue Coculture

    Published on: April 28, 2015

    29.8K

    Related Experiment Videos

    Last Updated: Mar 24, 2026

    Scalable Fabrication of Stretchable, Dual Channel, Microfluidic Organ Chips
    14:44

    Scalable Fabrication of Stretchable, Dual Channel, Microfluidic Organ Chips

    Published on: October 20, 2018

    27.7K
    Generation of a Human iPSC-Based Blood-Brain Barrier Chip
    10:20

    Generation of a Human iPSC-Based Blood-Brain Barrier Chip

    Published on: March 2, 2020

    13.8K
    The Multi-organ Chip - A Microfluidic Platform for Long-term Multi-tissue Coculture
    10:05

    The Multi-organ Chip - A Microfluidic Platform for Long-term Multi-tissue Coculture

    Published on: April 28, 2015

    29.8K

    Area of Science:

    • Pharmaceutical sciences
    • Biotechnology
    • Drug discovery and development

    Background:

    • The pharmaceutical industry, historically lucrative, faces unprecedented strain.
    • Factors include escalating development costs and extended timelines.
    • Poor predictive power of preclinical studies exacerbates challenges.

    Purpose of the Study:

    • To analyze the multifaceted pressures on the contemporary drug development pipeline.
    • To examine the impact of evolving healthcare demands on drug discovery.
    • To identify key areas of strain within the current drug development process.

    Main Methods:

    • Literature review of industry reports and scientific publications.
    • Analysis of economic trends in pharmaceutical research and development.
    • Assessment of emerging healthcare needs and their influence on pipeline priorities.

    Main Results:

    • Increased costs and lengthy timelines are primary constraints.
    • Preclinical study limitations significantly impact success rates.
    • Personalized medicine, chronic diseases, and infectious disease threats create new pressures.

    Conclusions:

    • The drug development pipeline requires significant adaptation to meet current and future demands.
    • Innovation in preclinical models and development strategies is crucial.
    • Addressing these strains is vital for public health and economic stability.